These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19780723)

  • 41. Ovarian cancer screening.
    Alexander-Sefre F; Menon U; Jacobs IJ
    Hosp Med; 2002 Apr; 63(4):210-3. PubMed ID: 11995270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian cancer early detection program.
    Farley KM
    Oncol Nurs Forum; 1999 Jun; 26(5):833-4. PubMed ID: 10382179
    [No Abstract]   [Full Text] [Related]  

  • 43. Is there a place for screening in ovarian cancer?
    MacDonald ND; Jacobs IJ
    Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):155-7. PubMed ID: 10206408
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening for ovarian cancer in the general population.
    Gentry-Maharaj A; Menon U
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):243-56. PubMed ID: 22182415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):557-71. PubMed ID: 1810100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian cancer screening.
    Rosenthal A; Jacobs I
    Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian cancer screening: a primary care guide.
    Thompson SD
    Lippincotts Prim Care Pract; 1998; 2(3):244-50. PubMed ID: 9644439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there any value in bimanual pelvic examination as a screening test.
    Grover SR; Quinn MA
    Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.
    Reade CJ; Riva JJ; Busse JW; Goldsmith CH; Elit L
    Gynecol Oncol; 2013 Sep; 130(3):674-81. PubMed ID: 23822892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary on 'Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening'.
    Wan Y; Crosbie E
    BJOG; 2014 Dec; 121 Suppl 7():40-7. PubMed ID: 25488087
    [No Abstract]   [Full Text] [Related]  

  • 51. HE4 in ovarian cancer: from discovery to clinical application.
    Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
    Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian cancer: screening, treatment, and followup.
    NIH Consens Statement; 1994 Apr 5-7; 12(3):1-30. PubMed ID: 7881476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
    Menon U; Talaat A; Rosenthal AN; Macdonald ND; Jeyerajah AR; Skates SJ; Sibley K; Oram DH; Jacobs IJ
    BJOG; 2000 Feb; 107(2):165-9. PubMed ID: 10688498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
    Buys SS; Partridge E; Greene MH; Prorok PC; Reding D; Riley TL; Hartge P; Fagerstrom RM; Ragard LR; Chia D; Izmirlian G; Fouad M; Johnson CC; Gohagan JK;
    Am J Obstet Gynecol; 2005 Nov; 193(5):1630-9. PubMed ID: 16260202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Screening for ovarian carcinoma].
    Broso P; Buffetti G
    Minerva Ginecol; 1993; 45(1-2):31-7. PubMed ID: 8469362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for ovarian cancer.
    Anderiesz C; Quinn MA
    Med J Aust; 2003 Jun; 178(12):655-6. PubMed ID: 12797860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of transvaginal ultrasonography for detecting ovarian cancer in an asymptomatic screening population: a systematic review.
    Buhling KJ; Lezon S; Eulenburg C; Schmalfeldt B
    Arch Gynecol Obstet; 2017 May; 295(5):1259-1268. PubMed ID: 28357559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
    Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
    Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.